 |
|
 |
Company Reports |
|
|
Haemonetics Corporation
Strategic Analysis Profile
Publication Date February 2008
Publisher Global Markets Direct
Product Type Strategic Report
Pages 40
ISBN Number not applicable
Product Code GMD268
|
|
|
Summary
The Haemonetics Corporation Strategic Analysis Profile is a comprehensive profile of the company including both quantitative and qualitative research. The report examines the Haemonetics Corporation's business structure and operations, history and products, and provides an analysis of its key revenue lines. The profile provides strategic insight on the company by examining its strategy, both in terms of its value chain positioning and strategic strengths and weaknesses in form of SWOT analysis. The SWOT section studies the major internal and external factors affecting the company. In addition the profile also includes a revenue analysis section which provides a breakdown of the companys' revenue by segment and key geographies.
Report Coverage
- Insightful company information, which addresses business and competitor intelligence needs.
- In-depth analysis of the operational aspects of the business including business descriptions, product lines and services revenue splits, and key competitors.
- Detailed financial and operational overview including key performance specific ratios.
- Strategic analysis of the company using SWOT and Value Chain analysis.
- Information on the company's history, key executives, locations and subsidiaries.
Why Buy?
- Support business/ sales activities by understanding customers' businesses better.
- Identify prospective partners and suppliers.
- Understand competitors' business structure, strategy and prospects.
- Analyze the latest market information and trends.
|
Content
- Chapter 1 Business Description
- Business Overview
- Donor Products Division
- Overview
- Financials
- Market View
- Patient Products Division
- Overview
- Financials
- Market View
- Major Products and Services
- Overview
- Chapter 2 History
- Chapter 3 Business Strategy
- Mission Statement
- Strategy
- Corporate Social Responsibility
- Overview
- Specific Csr Initiatives
- Chapter 4 Value Chain Analysis
- Product Development
- Overview
- Financials, Production and Major Projects
- Chapter 5 SWOT Analysis
- Overview
- Haemonetics Corporation Strengths
- Strong R&D Capability
- New Product Launches
- Efficiency in Operations
- Haemonetics Corporation Weaknesses
- Lower Returns
- Low Sales Growth Rate
- Haemonetics Corporation Opportunities
- Aging U.S. Population
- Rise in The U.S. Healthcare Spending
- Strategic Acquisitions
- Haemonetics Corporation Threats
- Change in Laws and Regulations
- Fluctuations in Currency Exchange Rates
- Risk of Communicable Diseases
- Chapter 6 Competitors
- Chapter 7 Revenue Analysis
- Revenue by Segment
- Revenue by Geography
- Chapter 8 Financial and Operational Review
- Chapter 9 Shareholding Structure
- Chapter 10 Key Employees
- Chapter 11 Key Employee Biographies
- Chapter 12 Company Statement
- Chapter 13 Locations and Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Chapter 14 Financial Deals Landscape
- Chapter 15 Recent Developments
- Chapter 16 Appendix
- Methodology
- about Global Markets Direct
- Contact US
- Disclaimer
- List of Tables
- Table 1: Haemonetics Corporation,Key Facts, 2007
- Table 2: Haemonetics Corporation, SWOT Analysis,, 2007
- Table 3: Haemonetics Corporation, SWOT Analysis,, 2007
- Table 4: Haemonetics Corporation Financial and Operational Overview, 2007-2003
- Table 5: Haemonetics Corporation Financial and Operational Overview, 2007-2003 (Contd.)
- Table 6: Haemonetics Corporation, 2007
- Table 7: Haemonetics Corporation,Key Employees, 2007
- Table 8: Haemonetics Corporation,Key Employees, 2007 (Contd.)
- Table 9: Haemonetics Corporation, Other Locations
- Table 10: Haemonetics Corporation, Subsidiaries
- List of Figures
- Figure 1: Haemonetics Corporation, Value Chain Analysis
|
|
|
